Immediate Release Melatonin for Parkinson's Disease
This trial will compare the effectiveness of two types of melatonin supplements in people with Parkinson's disease and a sleep disorder.
- Parkinson's Disease
- REM Sleep Behavior Disorder
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many human participants are partaking in this clinical experiment?
"Affirmative, the clinical trial is currently in search of participants. It was first announced on May 1st 2022 and its information was most recently updated on May 24th 2022. This medical study requires 50 enrollees from a single site."
Is there still room available for volunteers in this research endeavor?
"Clinicaltrials.gov confirms that this experiment is recruiting volunteers, with the first posting taking place on May 1st 2022 and being revised as recently as May 24th of the same year."